查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1763150

全球自动免疫检测设备市场

Automated Immunoassay Analyzers
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球自动免疫检测设备市场规模将达 47 亿美元

全球自动化免疫检测设备市场规模预计在2024年为36亿美元，预计到2030年将达到47亿美元，2024年至2030年的复合年增长率为4.5% 。萤光是本报告分析的细分市场之一，预计其复合年增长率为4.7%，到分析期结束时规模将达到12亿美元。化学冷光免疫检测测定 (CLIA) 细分市场在分析期间的复合年增长率预计为4.3%。

美国市场规模估计为 9.933 亿美元，中国市场预期复合年增长率为 4.4%

美国自动化免疫检测市场规模预计在2024年达到9.933亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到7.544亿美元，在2024-2030年的分析期间内，复合年增长率为4.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.2%和3.7%。在欧洲，预计德国市场的复合年增长率为4.4%。

全球自动免疫检测仪器市场—主要趋势与驱动因素摘要

为什么自动免疫检测设备对于现代诊断至关重要？

自动化免疫检测设备能够快速、准确、高通量地检测生物样本，从而彻底革新诊断实验室。这些仪器对于检测和定量血液及其他体液中的特定蛋白质、荷尔蒙和抗体至关重要，在感染疾病诊断、肿瘤学和内分泌学等领域中发挥重要作用。随着医疗保健系统重视早期检测和个人化医疗，免疫测量已成为诊断爱滋病毒、癌症、糖尿病等疾病的重要工具。这些检测的自动化不仅降低了人为错误的风险，还提高了诊断实验室的效率，使其能够以最少的人工处理大量样本。随着全球对诊断检测需求的不断增长，自动化免疫检测设备正成为现代医疗保健的重要组成部分。

科技进步如何增强自动免疫检测设备？

技术创新显着提升了自动化免疫检测仪器的功能和准确性。化学冷光和萤光等检测方法的进步提高了灵敏度和特异性，从而能够更快、更准确地检测生物标记。此外，人工智慧 (AI) 和机器学习演算法正在整合到这些系统中，以优化复杂数据的分析和解读，帮助临床医生做出更明智的诊断决策。自动化也延伸到了样品製备和数据管理领域，进一步简化了工作流程，缩短了获得结果的时间。随着实验室寻求缩短週转时间和提高业务效率，这些技术进步正在推动自动化免疫检测仪器的广泛应用。

哪些法规和合规标准管理自动免疫检测设备的使用？

监管监督在自动化免疫检测市场中至关重要，因为诊断测试的准确性和可靠性直接影响患者的治疗。美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等机构执行严格的指导方针，以确保免疫检测分析分析仪在上市前符合安全性和有效性标准。这些法规要求製造商进行严格的临床试验，并在生产过程中保持品管。此外，对于使用这些系统的实验室来说，遵守ISO 15189等管理医学实验室能力的国际标准至关重要，以确保测试结果的准确性和可靠性。遵守这些法律规范对于市场扩张至关重要，尤其是在北美和欧洲等监管严格的地区。

哪些因素推动了自动免疫检测市场的成长？

自动化免疫检测设备市场的成长受到多种因素的推动，包括对诊断测试日益增长的需求、慢性病盛行率的上升以及提高测试效率和准确性的技术进步。感染疾病、癌症和糖尿病等疾病的日益普及推动了对更先进诊断工具的需求，而免疫检测在其中发挥核心作用。个人化医疗需要准确的生物标记检测，这进一步推动了对这些分析仪的需求。此外，自动化和人工智慧整合的进步正在提高实验室的生产力，使医疗机构能够在保持品质的同时处理更大的测试量。最后，在医疗基础设施改善的推动下，新兴市场诊断测试的扩展正在创造新的成长机会。

部分

最终用途（医院、诊断实验室、血库、其他最终用途）、技术（萤光、化学冷光免疫检测(CLIA)、酵素萤光免疫分析(ELFA)、酵素结合免疫吸附检测法(ELISA)、免疫测量(RIA)、其他技术）

受访公司范例

  • Artron Laboratories, Inc.
  • Awareness Technology, Inc.
  • Beckman Coulter（UK）Ltd.
  • Chengdu Empsun Medical Co., Ltd.
  • Diagnostic Automation/Cortez Diagnostics, Inc.
  • DiaSorin SpA
  • DRG Instruments GmbH
  • Erba Mannheim
  • Guangzhou Wondfo Biotech Co., Ltd
  • H&W Biotech Oy

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP16161

Global Automated Immunoassay Analyzers Market to Reach US$4.7 Billion by 2030

The global market for Automated Immunoassay Analyzers estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.7 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Chemiluminescence Immunoassay (CLIA) segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$993.3 Million While China is Forecast to Grow at 4.4% CAGR

The Automated Immunoassay Analyzers market in the U.S. is estimated at US$993.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$754.4 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Automated Immunoassay Analyzers Market - Key Trends & Drivers Summarized

Why Are Automated Immunoassay Analyzers Vital for Modern Diagnostics?

Automated immunoassay analyzers are revolutionizing diagnostic laboratories by enabling rapid, accurate, and high-throughput testing of biological samples. These instruments are crucial for detecting and quantifying specific proteins, hormones, and antibodies in blood or other fluids, making them essential in areas such as infectious disease diagnostics, oncology, and endocrinology. As healthcare systems prioritize early detection and personalized medicine, immunoassays have become a critical tool for diagnosing conditions such as HIV, cancer, and diabetes. The automation of these tests not only reduces the risk of human error but also increases the efficiency of diagnostic labs, enabling them to process large volumes of samples with minimal manual intervention. As the demand for diagnostic testing grows globally, automated immunoassay analyzers are becoming integral to modern healthcare.

How Are Technological Advancements Enhancing Automated Immunoassay Analyzers?

Technological innovations are significantly improving the capabilities and accuracy of automated immunoassay analyzers. Enhanced sensitivity and specificity, driven by advancements in detection methods such as chemiluminescence and fluorescence, are enabling earlier and more precise detection of biomarkers. Moreover, the integration of artificial intelligence (AI) and machine learning algorithms into these systems is optimizing the analysis and interpretation of complex data, helping clinicians make more informed diagnostic decisions. Automation is also extending to sample preparation and data management, further streamlining workflows and reducing the time required for results. As labs seek to improve turnaround times and operational efficiency, these technological advancements are driving the widespread adoption of automated immunoassay analyzers.

What Regulatory and Compliance Standards Govern the Use of Automated Immunoassay Analyzers?

Regulatory oversight is critical in the automated immunoassay analyzers market, as the accuracy and reliability of diagnostic tests directly impact patient care. Agencies such as the FDA and European Medicines Agency (EMA) enforce strict guidelines to ensure that immunoassay analyzers meet safety and efficacy standards before they are introduced to the market. These regulations require manufacturers to conduct rigorous clinical trials and maintain quality control during production. Additionally, compliance with international standards such as ISO 15189, which governs the competence of medical laboratories, is essential for labs using these systems to ensure that their test results are accurate and reliable. Adherence to these regulatory frameworks is necessary for market expansion, especially in highly regulated regions such as North America and Europe.

What Factors Are Driving the Growth of the Automated Immunoassay Analyzers Market?

The growth in the automated immunoassay analyzers market is driven by several factors, including the rising demand for diagnostic testing, the increasing prevalence of chronic diseases, and technological advancements that improve testing efficiency and accuracy. The growing incidence of infectious diseases and conditions such as cancer and diabetes is driving the need for more sophisticated diagnostic tools, where immunoassays play a central role. The trend toward personalized medicine, which requires precise biomarker detection, is further boosting demand for these analyzers. Additionally, advancements in automation and AI integration are enhancing lab productivity, allowing healthcare facilities to handle higher test volumes while maintaining quality. Finally, the expansion of diagnostic testing in emerging markets, fueled by improvements in healthcare infrastructure, is creating new opportunities for growth.

SCOPE OF STUDY:

The report analyzes the Automated Immunoassay Analyzers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Diagnostic Laboratories, Blood Bank, Other End-Uses); Technology (Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Other Technologies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Artron Laboratories, Inc.
  • Awareness Technology, Inc.
  • Beckman Coulter (UK) Ltd.
  • Chengdu Empsun Medical Co., Ltd.
  • Diagnostic Automation / Cortez Diagnostics, Inc.
  • DiaSorin SpA
  • DRG Instruments GmbH
  • Erba Mannheim
  • Guangzhou Wondfo Biotech Co., Ltd
  • H&W Biotech Oy

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Automated Immunoassay Analyzers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Driving Adoption of Immunoassay Analyzers
    • Technological Advancements in Automated Analyzers Boosting Market Growth
    • Growing Focus on Early Disease Detection Supporting Demand for Immunoassay Solutions
    • Rising Adoption in Clinical Laboratories for High-Throughput Testing Fuelling Growth
    • Expansion of Point-of-Care Diagnostics Enhancing Immunoassay Analyzer Market Demand
    • Increasing Healthcare Spending in Emerging Economies Boosting Market Opportunities
    • Rising Awareness of Personalized Medicine Supporting Use of Advanced Immunoassays
    • Growth of Infectious Disease Testing Requirements Supporting Analyzer Adoption
    • Development of Multiplex Testing Platforms Fuelling Innovations in Immunoassay Analyzers
    • Stringent Regulatory Standards for Laboratory Testing Supporting Automated Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Automated Immunoassay Analyzers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Automated Immunoassay Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Automated Immunoassay Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Immunofluorescence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay (CLIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chemiluminescence Immunoassay (CLIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chemiluminescence Immunoassay (CLIA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Radioimmunoassay (RIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Radioimmunoassay (RIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Radioimmunoassay (RIA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Blood Bank by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Blood Bank by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Blood Bank by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Automated Immunoassay Analyzers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Automated Immunoassay Analyzers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION